BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND P2RY8, RP11-261P4_4, 286530, ENSG00000182162, MGC50878, P2Y8, Q86VZ1 AND Treatment
9963 results:

  • 1. Hyponutrition among newly diagnosed gastric cancer.
    Pham VT; Nguyen MLT; Pham C; LE QV; Tran DH; LE TS; Nguyen LT; Bui KC
    Bratisl Lek Listy; 2024; 125(6):392-398. PubMed ID: 38757598
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A humanized trivalent Nectin-4-targeting nanobody drug conjugate displays potent antitumor activity in gastric cancer.
    Wu Y; Zhu M; Sun B; Chen Y; Huang Y; Gai J; Li G; Li Y; Wan Y; Ma L
    J Nanobiotechnology; 2024 May; 22(1):256. PubMed ID: 38755613
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Nutritional responsiveness affects novel neutrophil parameters and reduces in-hospital mortality and costs in elective cancer oesophagectomy - a single centre, prospective, observational study.
    Kutnik P; Borys M; Nurczyk K; Domerecka W; Dziedzic J; Buszewicz G; Teresiński G; Donica H; Piwowarczyk P; Czuczwar M
    Anaesthesiol Intensive Ther; 2024; 56(1):77-82. PubMed ID: 38741447
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Feasibility of laparoscopic and endoscopic cooperative surgery for gastric gastrointestinal stromal tumor with tumor diameter of >5 cm.
    Iwakawa Y; Nishi M; Wada Y; Yoshikawa K; Takasu C; Tokunaga T; Nakao T; Kashihara H; Yoshimoto T; Noma T; Shimada M
    J Med Invest; 2024; 71(1.2):148-153. PubMed ID: 38735711
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Low prognostic nutrition index as a prognostic biomarker in elderly patients with early gastric cancer after gastrectomy.
    Takahashi T; Kaneoka Y; Maeda A; Takayama Y; Aoyama H; Hosoi T; Seita K
    J Med Invest; 2024; 71(1.2):113-120. PubMed ID: 38735706
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. An In Vitro Study on the Cytotoxic, Antioxidant, and Antimicrobial Properties of Yamogenin-A Plant Steroidal Saponin and Evaluation of Its Mechanism of Action in gastric cancer Cells.
    Stefanowicz-Hajduk J; Graczyk P; Hering A; Gucwa M; Nowak A; Hałasa R
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731847
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Intraperitoneal chemotherapy for peritoneal metastases of gastric origin: a systematic review and meta-analysis.
    Guchelaar NAD; Nasserinejad K; Mostert B; Koolen SLW; van der Sluis PC; Lagarde SM; Wijnhoven BPL; Mathijssen RHJ; Noordman BJ
    Br J Surg; 2024 May; 111(5):. PubMed ID: 38722803
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Efficacy and safety of surufatinib plus toripalimab, a chemotherapy-free regimen, in patients with advanced gastric/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, or biliary tract cancer.
    Zhang P; Chen Z; Shi S; Li Z; Ye F; Song L; Zhang Y; Yin F; Zhang X; Xu J; Cheng Y; Su W; Shi M; Fan S; Tan P; Zhong C; Lu M; Shen L
    Cancer Immunol Immunother; 2024 May; 73(7):119. PubMed ID: 38713205
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Is there any difference between Eastern and Western clinical practice guidelines in management of gastric cancer?
    Jalaeefar A; Mousavi SZ; Shirkhoda M; Mahmoodzadeh H; Mohammadzadeh N; Sharifi A
    Cancer Rep (Hoboken); 2024 May; 7(5):e2076. PubMed ID: 38711281
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Glucagon-like peptide-1 analogs activate AMP kinase leading to reversal of the Warburg metabolic switch in breast cancer cells.
    Ligumsky H; Amir S; Arbel Rubinstein T; Guion K; Scherf T; Karasik A; Wolf I; Rubinek T
    Med Oncol; 2024 May; 41(6):138. PubMed ID: 38705935
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Biosynthesized BiFe
    Shamsi H; Yari R; Salehzadeh A
    Sci Rep; 2024 May; 14(1):10284. PubMed ID: 38704421
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Contemporary outcomes for resected type 1-3 gastroesophageal junction adenocarcinoma: a single-center experience.
    Stiles ZE; Hagerty BL; Brady M; Mukherjee S; Hochwald SN; Kukar M
    J Gastrointest Surg; 2024 May; 28(5):634-639. PubMed ID: 38704200
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Real-world safety and effectiveness of anamorelin for cancer cachexia: Interim analysis of post-marketing surveillance in Japan.
    Takayama K; Kojima A; Honda C; Nakayama M; Kanemata S; Endo T; Muro K
    Cancer Med; 2024 May; 13(9):e7170. PubMed ID: 38693813
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical impact of skeletal muscle mass change during the neoadjuvant chemotherapy period in patients with gastric cancer: An ancillary study of JCOG1002.
    Sato R; Tokunaga M; Mizusawa J; Sato Y; Ito S; Takahari D; Sano T; Onaya H; Yoshikawa T; Boku N; Terashima M
    World J Surg; 2024 Jan; 48(1):163-174. PubMed ID: 38686798
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Risk factors associated with lymph node metastasis in early-stage distal gastric cancer.
    Yu Z; Liang C; Li R; Gao J; Gao Y; Zhou S; Li P
    World J Surg; 2024 Jan; 48(1):151-162. PubMed ID: 38686759
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. EBV-Associated gastric cancer; An In Situ Hybridization Assay on Tissue Microarray: A Multi-Region Study from Four Major Provinces of Iran.
    Abolhasani M; Mohseni AO; Shakeri R; Khavanin A; Khajehei M; Omidi A; Geramizadeh B; Shafigh E; Naghshvar F; Fathizadeh P; Taghizadehgan L; Gharib A; Gulley ML; Dawsey SM; Malekzadeh R; Rabkin CS; Vasei M
    Arch Iran Med; 2024 Apr; 27(4):191-199. PubMed ID: 38685845
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The Clinical Impact of the Prognostic Immune and Nutritional Index in gastric cancer Patients Who Received Curative treatment.
    Aoyama T; Hashimoto I; Maezawa Y; Hara K; Tamagawa A; Cho H; Morita J; Tanabe M; Numata M; Kawahara S; Oshima T; Saito A; Yukawa N
    Anticancer Res; 2024 May; 44(5):2231-2238. PubMed ID: 38677750
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The Important Role of GPX1 and NF-κB Signaling Pathway in Human gastric cancer: Implications for Cell Proliferation and Invasion.
    Jang BI; Jung JY; Koh SA; Lee KH
    Cancer Genomics Proteomics; 2024 Apr; 21(3):305-315. PubMed ID: 38670589
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Impact of data transfer between treatment planning systems on dosimetric parameters.
    Meffe G; Votta C; Turco G; Chillè E; Nardini M; Romano A; Chiloiro G; Panza G; Galetto M; Capotosti A; Moretti R; Gambacorta MA; Boldrini L; Indovina L; Placidi L
    Phys Med; 2024 May; 121():103369. PubMed ID: 38669811
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Creatinine-to-cystatin C ratio and body composition predict response to PD-1 inhibitors-based combination treatment in metastatic gastric cancer.
    Ji H; Liu B; Jin P; Li Y; Cui L; Jin S; Wu J; Shan Y; Zhang Z; Ming J; Zhang L; Du C
    Front Immunol; 2024; 15():1364728. PubMed ID: 38665913
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 499.